Related Experiment Videos
Absence of a pharmacokinetic interaction between enalapril and frusemide
British Journal of Clinical Pharmacology
|January 1, 1987
Abstract:
Single doses of enalapril maleate 10 mg and frusemide 80 mg do not significantly affect the pharmacokinetics of each other when taken concomitantly. Their concomitant use may be associated with more adverse effects than with the individual entities.
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Estradiol and weight are covariates of paracetamol clearance in young women.
Gynecologic and obstetric investigation·2014
Weight, pregnancy and oral contraceptives affect intravenous paracetamol clearance in young women.
European review for medical and pharmacological sciences·2014
Pharmacokinetics of intravenous ketorolac following caesarean delivery.
International journal of obstetric anesthesia·2012
Cefazolin plasma protein binding and its covariates in neonates.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2012
Pharmacokinetics of a loading dose of intravenous paracetamol post caesarean delivery.
International journal of obstetric anesthesia·2012
Alpha lipoic acid for prevention of radiation-induced dermatitis in breast cancer patients: A randomized-controlled trial.
British journal of clinical pharmacology·2026
Anti-HER2 therapy-associated echocardiography-related cardiac dysfunction and severe outcomes: Comparison of disproportionality and report-level cluster analyses.
British journal of clinical pharmacology·2026
Toward a paradigm of protection through research: Earlier and more ethical inclusion of pregnant and breastfeeding women in clinical trials.
British journal of clinical pharmacology·2026
Acute toxic leucoencephalopathy following protonitazene ingestion.
British journal of clinical pharmacology·2026
The potential impact of H1 antihistamines on clinical outcomes in NSCLC patients undergoing EGFR-TKIs treatment.
British journal of clinical pharmacology·2026
Special Populations in Pivotal Clinical Trials: Eligibility and Supporting Evidence for Exclusion in EMA-Authorised Medicines.
Clinical pharmacology and therapeutics·2026
Pharmacogenomic and Medicinal Chemistry Perspectives on Off-label Drug Use.
Mini reviews in medicinal chemistry·2026
A SHAP-Informed Formal Feature Attribution Framework for Drug-Drug Interaction Risk in Large-Scale Claims Data.
Clinical and translational science·2026
Qualitative evidence of service user experiences and perspectives on long-acting injectable buprenorphine for opioid treatment - a scoping review.
The International journal on drug policy·2026
US postmarketed drug removals: Analysis of discontinued and withdrawn drugs.
The Journal of pharmacology and experimental therapeutics·2026
Examining Increased Ritalin and Adderall Use Among Low-Income People Who Use Drugs: Mixed Methods Study.
JMIR formative research·2026